menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Reducing the Burden of HPV-associated Cancer & Disease, Part 3

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.

    This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.

    This is Part 3 of a lecture in three parts.

    Part 1 >>

    Part 2 >>

    To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    This session of Grand Rounds explores the burden of human papillomavirus (HPV) -associated cancer and disease in the United States and prevention through HPV vaccination. Each year, there are an estimated 26,000 HPV-attributable cancers in the United States. About 17,000 occur in women, most of which are cervical cancers, and about 9,000 occur in men, most of which are oropharyngeal cancers. CDC estimates that $8 billion are spent each year on direct medical costs for preventing and treating HPV-associated disease.

    This session provides more insight about the HPV vaccination program and how CDC, state and local health departments, and health care providers are working together to achieve high vaccination levels and reduce the substantial burden of HPV-associated disease.

    This is Part 3 of a lecture in three parts.

    Part 1 >>

    Part 2 >>

    To view the complete video recording of this and other CDC Public Health Grand Rounds sessions, visit http://www.cdc.gov/about/grand-rounds/

Facebook Comments

Schedule28 Mar 2024